Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Dr Reddys Laboratories (RDY) over the last 14 years, with Q4 2025 value amounting to $427.0 million.

  • Dr Reddys Laboratories' Other Non-Current Liabilities changed N/A to $427.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $427.0 million, marking a year-over-year change of. This contributed to the annual value of $39.0 million for FY2025, which is 1875.0% down from last year.
  • Per Dr Reddys Laboratories' latest filing, its Other Non-Current Liabilities stood at $427.0 million for Q4 2025.
  • Dr Reddys Laboratories' 5-year Other Non-Current Liabilities high stood at $427.0 million for Q4 2025, and its period low was $382.65 during Q2 2022.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $323.9 million (2021), whereas its average is $222.8 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 9999.99% in 2022, then skyrocketed by 10053907315.89% in 2023.
  • Dr Reddys Laboratories' Other Non-Current Liabilities (Quarter) stood at $325.0 million in 2021, then increased by 6.0% to $344.5 million in 2022, then rose by 8.52% to $373.8 million in 2023, then plummeted by 80.76% to $71.9 million in 2024, then skyrocketed by 493.8% to $427.0 million in 2025.
  • Its Other Non-Current Liabilities was $427.0 million in Q4 2025, compared to $27.0 million in Q3 2025 and $426.3 million in Q1 2025.